Lawrence Kenyon
Interim Chief Executive Officer, CFO, Treas & Sec'y
Outlook Therapeutics, Inc.
Joined January 2025BiotechnologyOphthalmic Biopharmaceuticals
Company
Position
Interim Chief Executive Officer, CFO, Treas & Sec'y
Outlook Therapeutics, Inc.
Document Signer
Responsibilities
- Oversees company operations
- Represents company in official filings
- Key decision maker
Notes
Location
Industry
Biotechnology
Ophthalmic Biopharmaceuticals
Industry Metrics
Market Size$8.2B
YoY Growth12.8%
Companies483